These observations further support our hypothesis that AML cells and normal CD34+ bone marrow cells differ with regard to integrin function but also iron metabolism (Figure 4) due to an increased expression of transferrin–transferrin receptors in CD34+ cells. The gene discussed is TFRC; the disease is acute myeloid leukemia.